Archive
Here you can find the archive of all Press Releases prior to 2018
Filter by date:
Showing 709 press releases before 2019
-
AstraZeneca PLC Second Quarter & Half Year Results 2009
-
AstraZeneca Terminates License Agreement with MAP Pharmaceuticals Regarding Unit Dose Budesonide
-
AstraZeneca to Advance AZD3480 in ADHD
-
IRESSA (Gefitinib) Receives Marketing Authorisation for the Treatment of Non-Small Cell Lung Cancer in Europe
-
AstraZeneca Development Partner, Pozen, Inc., Submits New Drug Application for PN400
AstraZeneca Development Partner, Pozen, Inc., Submits New Drug Application for PN400
-
ONGLYZA (saxagliptin) Receives Positive Opinion in Europe for the Treatment of Type 2 Diabetes
-
Favourable Vote from FDA Advisory Committee on Seroquel Paediatric Supplemental New Drug Applications
-
AstraZeneca and Abbott Extend Relationship to Include Co-Promotion of Trilipix
Latest articles and press releases
All of our latest press releases and articles are available to explore
Contact us
Email the Global Media Relations team at:
Gonzalo Viña
Head of Global Media Relations
+44 (0)1223 344 800
Kim Blomley
Director Global Media Relations (Oncology)
+44 (0)1223 344 800
Matthew Kent
Director Global Media Relations (BioPharmaceuticals)
+44 (0)1223 344 800
Angela Fiorin
Director Global Media Relations (BioPharmaceuticals)
+44 (0)1223 344 800
Fiona Cookson
Director Global Media Relations (Covid-19)
+44 (0)1223 344 800
Christina Malmberg Hägerstrand
Media Relations Director, Sweden and Nordic-Baltic
+46 855 253 106
